rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    EMBC
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Why Embecta Bears Were Right Before A 54% Drop

      If you had paused on Embecta in late 2025, wondering whether steady diabetes-device cash flows and analyst price targets justified a position, the past year has delivered a harsh answer. Investors who held Embecta over the past year are down 53.6%, including dividends. With lawsuits now alleging misleading guidance and weak pen needle demand, the real question is which assumptions about earnings visibility and product resilience were already sitting in plain sight back on 6 November...

      Nov 7Yahoo FinanceEMBC
      What Embecta Bears Saw Before A 55% Drop

      If you had backed Embecta on 19 October 2025 and simply held on, the experience would have been brutal. Holding Embecta over the past year would have meant a 54.5% loss, including dividends. At the start, bullish and bearish analysts were arguing over modest revenue shrinkage, margin expansion into the mid teens, and a future P/E between 7.4x and 4.7x. So what did that original investment case miss about pen needle reliance, GLP-1 partnerships and margin durability? The move put Embecta in...

      Oct 20Yahoo FinanceEMBC
      Analysts Offer Insights on Healthcare Companies: Embecta Corporation (EMBC) and Airsculpt Technologies (AIRS)

      Tipranks Press Release.

      Oct 13The Globe and MailAIRSEMBC
      Embecta director Milton Mayo sells $36,971 in shares
      Sep 8Investing.comEMBC
      embecta to Participate in Investor Events

      PARSIPPANY, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events: Wells Fargo 2026 Healthcare ConferenceManagement will host one-on-one investor meetings on Wednesday, September 9, 2026, at the Encore Boston Harbor Hotel in Everett, Boston, MA.J.P. Morgan 4th Annu

      Aug 31Yahoo FinanceEMBC
      The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products
      Aug 25Seeking AlphaEMBC

      This is the newest page. Registered accounts read further back.